[Federal Register Volume 85, Number 62 (Tuesday, March 31, 2020)]
[Notices]
[Page 17868]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06690]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal
Advisory Committee Meeting; Modification
AGENCY: Under Secretary of Defense for Personnel and Readiness,
Department of Defense (DoD).
ACTION: Notice of Federal Advisory Committee meeting; modification.
-----------------------------------------------------------------------
SUMMARY: On February 26, 2020, the DoD published a notice to announce
the April 1, 2020 meeting of the Uniform Formulary Beneficiary Advisory
Panel. On March 9, 2020, the DoD published a notice that announced that
the meeting time had changed. DoD is publishing this notice to announce
that this federal advisory committee meeting has been modified to a
remote access format.
DATES: Open to the public Wednesday, April 1, 2020 from 12:00 p.m. to
3:00 p.m.
ADDRESSES: The address of the open meeting will be online. The phone
number for the remote access is: CONUS: 888-469-2037; OCONUS: 1-517-
308-9287; PARTICIPANT CODE: 8227323. These numbers and the dial-in
instructions will also be posted on the Uniform Formulary Beneficiary
Advisory Panel website at: https://www.health.mil/About-MHS/OASDHA/Defense-Health-Agency/Operations/Pharmacy-Division/Beneficiary-Advisory-Panel.
FOR FURTHER INFORMATION CONTACT: Colonel Paul J. Hoerner, USAF, 703-
681-2890 (Voice), None (Facsimile), [email protected] (Email). Mailing address is 7700 Arlington
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://www.health.mil/About-MHS/OASDHA/Defense-Health-Agency/Operations/Pharmacy-Division/Beneficiary-Advisory-Panel. The most up-to-date
changes to the meeting agenda can be found on the website.
SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of
the Department of Defense, the Designated Federal Officer for the
Uniform Formulary Beneficiary Advisory Panel was unable to provide
public notification required by 41 CFR 102-3.150(a) concerning the
modification of the previously noticed meeting for April 1, 2020.
Accordingly, the Advisory Committee Management Officer for the
Department of Defense, pursuant to 41 CFR 102-3.150(b), waives the 15-
calendar day notification requirement.
On February 26, 2020 (85 FR 11053-11054), the Department of Defense
published a notice that announced an April 1, 2020 meeting of the
Uniform Formulary Beneficiary Advisory Panel. On March 9, 2020 (85 FR
13636), the DoD published a notice that announced that the meeting time
had changed. DoD is publishing this notice to announce that this
federal advisory committee meeting has been modified to a remote access
format.
Written Statements: Pursuant to 41 CFR 102-3.10, and section
10(a)(3) of FACA, interested persons or organizations may submit
written statements to the Uniform Formulary Beneficiary Advisory Panel
about its mission and/or the agenda to be addressed in this public
meeting. Written statements should be submitted to the Uniform
Formulary Beneficiary Advisory Panel's DFO. The DFO's contact
information can be found in the FOR FURTHER INFORMATION CONTACT section
of this notice. Written comments or statements must be received by the
Uniform Formulary Beneficiary Advisory Panel's DFO at least five (5)
business days prior to the meeting so they may be made available to the
Uniform Formulary Beneficiary Advisory Panel for its consideration
prior to the meeting. The Designated Federal Officer will review all
submitted written statements and provide copies to all Uniform
Formulary Beneficiary Advisory Panel members.
Dated: March 26, 2020.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2020-06690 Filed 3-30-20; 8:45 am]
BILLING CODE 5001-06-P